Due to concern about a possible link between bisphosphonates and cardiac arrhythmias, an observational study looked at whether alendronate use is related to incident atrial fibrillation risk in women. The North American Menopause Society (NAMS)
Plagued by controversy and attracting the watchful eye of congressional committees in the US, ENHANCE stepped into the spotlight at the American College of Cardiology 2008 Scientific Sessions. Not surprisingly, there was no shortage of opinions about what the results mean to clinical practice. Heartwire
Pulse oximetry screening performed in the first hours of life improves the detection of potentially life-threatening congenital heart defects and other severe diseases in apparently healthy newborns. Reuters Health Information
Frank Sacks, MD, provides an overview on CVD risk factors in patients with metabolic syndrome, with a focus on treatment options and management of mixed dyslipidemia for reducing CVD risk. Medscape Cardiology
Stress cardiomyopathy is reviewed and the authors suggest a novel pathophysiological explanation that focuses on the direct effects of high epinephrine levels on the ventricular myocardium. Nature Clinical Practice Cardiovascular Medicine
Dr. Simon A. Mallal discusses the latest data from CROI 2008 in regard to the metabolic comorbidities associated with HIV infection and antiretroviral therapy. Medscape HIV/AIDS
